EX-10.2 9 d621319dex102.htm EX-10.2 ASSIGNMENT AND ASSUMPTION OF LEASEAssignment and Assumption of Lease • May 5th, 2020
Contract Type FiledMay 5th, 2020This Assignment and Assumption of Lease (“Assignment”) is entered into and made effective as of the 1st day of April, 2017, by and between METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC a Delaware limited liability company (“Assignor”) and CIRIUS THERAPEUTICS, INC., a Delaware corporation (“Assignee”), and consented to by MAIN STREET EAST, LLC, a Michigan limited liability company (“Landlord”).
ASSIGNMENT AND ASSUMPTION OF LEASEAssignment and Assumption of Lease • January 11th, 2019 • Cirius Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 11th, 2019 Company IndustryThis Assignment and Assumption of Lease (“Assignment”) is entered into and made effective as of the 1st day of April, 2017, by and between METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC a Delaware limited liability company (“Assignor”) and CIRIUS THERAPEUTICS, INC., a Delaware corporation (“Assignee”), and consented to by MAIN STREET EAST, LLC, a Michigan limited liability company (“Landlord”).
ASSIGNMENT AND ASSUMPTION OF LEASEAssignment and Assumption of Lease • October 11th, 2018 • Cirius Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 11th, 2018 Company IndustryThis Assignment and Assumption of Lease (“Assignment”) is entered into and made effective as of the 1st day of April, 2017, by and between METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC a Delaware limited liability company (“Assignor”) and CIRIUS THERAPEUTICS, INC., a Delaware corporation (“Assignee”), and consented to by MAIN STREET EAST, LLC, a Michigan limited liability company (“Landlord”).